Yasodha Natkunam, M.D., Ph.D

Yasodha Natkunam, M.D., Ph.D

Pathologist, Hematopathologist, Surgical pathologist, Immunodiagnosis pathologist


Ronald F. Dorfman, MBBch, FRCPath Professor of Hematopathology

View Professional Summary »


Additional Languages Spoken:
Tamil

Biography


Dr. Natkunam is an expert in the diagnosis of hematopoietic tumors including lymphoma and leukemia and has 20-years of experience in the hematopathology diagnostic services of Stanford Health and Stanford Children’s Health. Her research focuses on refining the diagnosis and prognosis of patients with hematopoietic tumors and has furnished novel reagents, diagnostic criteria and guidelines for clinical practice. She currently serves on a number of editorial boards, expert panels and professional societies in her field.

Professional Summary


Education & Certifications
  • Medical Education: Icahn School of Medicine at Mount Sinai Department of Surgery-Division of General Surgery (1995) NY
  • Residency: Stanford University Pathology Residency (1999) CA
  • AB, Bryn Mawr College, Biology (1987)
  • PhD, Mount Sinai School of Medicine, Molecular Biology (1993)
  • MD, Mount Sinai School of Medicine, Medical School (1995)
  • Board Certification: American Board of Pathology, Anatomic Pathology (1998)

Honors & Awards
  • Faculty Teaching Award, Department of Pathology, Stanford (2016)
  • Faculty Teaching Award, Department of Pathology, Stanford (2017)
  • Faculty Teaching Award, Department of Pathology, Stanford (2019)
  • Faculty Teaching Award, Department of Pathology, Stanford (2021)
  • International Cancer Technology Transfer Award, International Cancer Control, Switzerland (2010)
  • Medical Scientist Training Program, Mount Sinai School of Medicine, New York (1987-1995)
  • Ronald F. Dorfman, MBBS, FRCPath Professor in Hematopathology, Stanford University School of Medicine (2018)
  • Shalit Fellow at John Radcliffe Hospital, Oxford, UK, Leukemia Research Fund, UK (2006)
  • Undergraduate Research Award, Charles A. Dana Foundation (1986)
  • Weill Memorial Fellow in Cancer Research, Mount Sinai School of Medicine, New York (1993)

Memberships
  • Section Editor, Laboratory Investigation (2007 - 2009)
  • Editorial Board, International Journal of Clinical and Experimental Pathology (2007 - 2016)
  • Editorial Board, Applied Immunohistochemistry and Molecular Morphology (2008 - 2016)
  • Editorial Board, Human Pathology (2008 - Present)
  • Lymphoma Working Group, Eastern Coorperative Oncology Group (2010 - Present)
  • Chair, Education Committee, Society for Hematopathology (2011 - 2013)
  • Editorial Board, American Journal of Surgical pathology (2011 - Present)
  • Member, Lunenberg Lymphoma Biomarker Consortium (2012 - Present)
  • Chair, Workshop on Immunodeficiency and Dysregulation, Society for Hematopathology (2015 - 2015)
  • Advisory Council, International Medical Health Organization (2017 - 2021)
  • Executive Committee, Society for Hematopathology (2017 - 2021)
  • International Affairs Committee, Society for Hematopathology (2020 - Present)
  • Board of Directors, International Medical Health Organization (2021 - Present)
  • Executive Committee, Global nLPHL One Working Group (2022 - Present)

Administrative Appointments
  • Co-Director, Immunodiagnosis Laboratory, Stanford (2005 - Present)
  • Director of Faculty Development and Diversity, Stanford (2009 - 2018)
  • Director of Hematopathology, Stanford (2009 - 2020)

Publications

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.


Specializing In

  • Pathology

Practice Locations


SHC- Pathology (300P) Stanford, CA
Stanford, CA

300 Pasteur Dr

Stanford , CA 94305

(650) 723-6041

More Clinic Information »